← All organizations
Highest phase reached
Phase 4
First clinical trial
Feb 28, 2015Last known activity
Jan 6, 2024
Timeline
No events for the selected filters.
Drugs by trial phase (4 distinct, 5 trials)
Phase 4 (2 own, 0 via acquisition)
Indications
Studied for
Recent trials (13)
- NCT06568588OfficialPhase 2Jan 6, 2024
- NCT06568588Lead sponsorPhase 2Jan 6, 2024
- NCT06568588Sponsor investigatorPhase 2Jan 6, 2024
- NCT04896359Lead sponsorN/AMar 15, 2019
- NCT04896359Reponsible party - principal investigatorN/AMar 15, 2019
- NCT04896359Overall official - principal investigatorN/AMar 15, 2019
- NCT03883334Study directorPhase 4Feb 28, 2019
- NCT03883334Lead sponsorPhase 4Feb 28, 2019
- NCT03883334Reponsible party - principal investigatorPhase 4Feb 28, 2019
- NCT04786938Lead sponsorPhase 4Apr 7, 2016
- NCT04786938Reponsible party - principal investigatorPhase 4Apr 7, 2016
- NCT04786938Overall official - principal investigatorPhase 4Apr 7, 2016
- NCT02446873CollaboratorN/AFeb 28, 2015
Details
- Last known activity
- Jan 6, 2024